Senesco Technologies, Inc. (AMEX: SNT)

Senesco Technologies, Inc. (AMEX: SNT) is focused on researching and developing genetic technologies that improve commercial agriculture and treat significant medical conditions. The company’s platform technology is based on the identification and characterization of specific genes known to be responsible for plant cell death (senescence) and programmed cell death in humans (apoptosis). Senesco’s patented pending genetic technologies have the advantage of having broad applicability. For further information, visit the Company’s web site at www.senesco.com.